PT Kalbe Farma Tbk. (PTKFF) Comparison with companies in other sectors?

PT Kalbe Farma Tbk. has a share price of 45.58B. You can analyze PT Kalbe Farma Tbk. (PTKFF) competitors across different market sectors through stock heatmaps.

What are PTKFF's NET and operating margins?

PT Kalbe Farma Tbk. (PTKFF) operating margin is around 0.13, and net profit margin is approximately 0.10 as of the latest reports.

In what way does PTKFF's earnings per share (EPS) trend reflect its financial momentum?

PT Kalbe Farma Tbk. (PTKFF) EPS is N/A (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for PT Kalbe Farma Tbk. is N/A, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for PT Kalbe Farma Tbk.?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for PT Kalbe Farma Tbk. like P/E which is 21.69, P/B which is 3.10, and PEG which is 0.00. Compare them with sector averages to evaluate if the stock is priced fairly.

PT Kalbe Farma Tbk.

PTKFF•PNK

Healthcare

Drug Manufacturers - General

$0.10

$0.003(3.01%)

PT Kalbe Farma Tbk. (PTKFF) Fundamental Analysis: Financial Health, Valuation, and Key Ratios

Dive into Apple Inc.’s fundamentals including valuation ratios, profitability, efficiency metrics, and financial health. Use this data to assess long-term investment quality and compare it with sector benchmarks.

EPS (TTM)

P/E Ratio

ROE

0.15%

Net Margin

0.10%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$4.37B

Shares OutstandingTotal number of shares issued

$45.58B

Book Value/ShareNet worth per share

$549.54

Revenue/ShareAnnual revenue per share

$717.46

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

Net MarginNet income as percentage of revenue

10.15%

Operating MarginOperating income as percentage of revenue

12.71%

ROEReturn on shareholders' equity

14.88%

ROAReturn on total assets

10.99%

ROCEReturn on capital employed

16.16%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$62.30

Cash/ShareCash and equivalents per share

$101.59

FCF YieldFree cash flow as percentage of market cap

3.99%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

$36.21

Dividend YieldAnnual dividend as percentage of stock price

2.29%

Financial Ratios Analysis data is not available for PTKFFFinancial Ratios Analysis details for PTKFF are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for PTKFFSector Benchmarking details for PTKFF are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for PT Kalbe Farma Tbk. Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of PT Kalbe Farma Tbk.. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account PT Kalbe Farma Tbk.'s unique business strengths and challenges.

Key Financial Metrics for PT Kalbe Farma Tbk.

For PT Kalbe Farma Tbk., essential financial indicators include EPS -, PE -, and ROE 0.15. These key ratios reveal insights into PT Kalbe Farma Tbk.'s profitability, valuation, and operational health. Understanding these metrics enables you to compare PT Kalbe Farma Tbk. with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of PT Kalbe Farma Tbk.

Metrics like Net Margin 10.15% and ROA 10.99% shed light on how well PT Kalbe Farma Tbk. is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether PT Kalbe Farma Tbk. can sustain its operations and continue growing in the future.

Valuation and Market Position of PT Kalbe Farma Tbk.

Using ratios such as P/B Ratio 3.10 and PEG Ratio 0.00, investors can assess whether PT Kalbe Farma Tbk. is appropriately valued based on its financials and growth potential. These figures, combined with PT Kalbe Farma Tbk.'s market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for PT Kalbe Farma Tbk.

Financial health indicators, such as Debt/Equity Ratio 0.02 and Cash Flow $62.30, provide a snapshot of PT Kalbe Farma Tbk.'s ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like PT Kalbe Farma Tbk., is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for PT Kalbe Farma Tbk.

Investing in PT Kalbe Farma Tbk. based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at PT Kalbe Farma Tbk. focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;